Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

NOAH calls for UK-EU vet medicine agreement
"Veterinary medicines must not be sidelined as a technical detail" - Dawn Howard, NOAH chief executive.
Political leaders will meet for a summit on 19 May.

The National Office of Animal Health (NOAH) has united with its EU counterpart, AnimalhealthEurope, to call for a veterinary medicines agreement between the UK and EU.

The groups warn that, since the UK's exit from the European Union, there has been no formal regulatory agreement on veterinary medicines.

They maintain that a veterinary agreement is vital not only for treating pets and livestock, but also to protect public health, ensure food security and support sustainable agriculture. Animal welfare in both the UK and the EU could be at risk.

A lack of regulatory co-operation is currently causing challenges which threaten product availability and innovation. While other regulatory agreements have diverged since Brexit, NOAH says that a lack of alignment in the veterinary medicines sector has caused unnecessary duplication, increased costs and risks to availability.

Political leaders are set to meet for the EU-UK Summit in London on 19 May 2025. NOAH and AnimalhealthEurope hope they will use the opportunity to agree on a dedicated veterinary medicines agreement.

The organisations suggest that the leaders could either agree on a standalone deal or include it as a specific chapter in a broader Sanitary and Phytosanitary (SPS) Agreement. NOAH and AnimalhealthEurope believe this will mean continued alignment across product authorisation, labelling, distribution and post-market surveillance.

Dawn Howard, chief executive of NOAH, said: “Veterinary medicines must not be sidelined as a technical detail—they are critical to the health of our animals, the safety of our food, and the growth of our economy.”

She added: “This moment is a great opportunity. The UK and the EU have the chance to show leadership in animal health and welfare, economic co-operation, and One Health. NOAH, together with AnimalhealthEurope, is ready to work with regulators and policymakers to secure this outcome.”

Roxane Feller, secretary general of AnimalhealthEurope, said: “Unlike politics, disease knows no borders. Guaranteed access to veterinary medicines is fundamental to safeguarding animal health and welfare, ensuring food security, and protecting public health under the One Health framework.

“AnimalhealthEurope, together with NOAH, has been calling for cooperation in the field of veterinary medicines since the publication of the Withdrawal Agreement and Political Declaration on the future relationship between the UK and the EU in 2018.”

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.